You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1901 to 1925 of about 5880
Next 25
03/15/2015
New clinical trials at JFK Brain Tumor Center in Edison, NJ
2nd Hoops For Hannah Bracket Contest
03/14/2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).
03/11/2015
Study: Tetanus Shot May Aid Treatment of Deadly Brain Cancer
03/07/2015
IBTA e-News
03/06/2015
How A Group Of Lung Cancer Survivors Got Doctors To Listen
02/26/2015
Israeli Company Develops Device to Fight Tumor Growth with Electric Fields
New clinical trial for Glioblastoma using immunotherapy
Quicker Access to Experimental Drugs
NW BIO`S PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER APPROVED TO PROCEED IN CANADA AND UNDER WAY AT TWO SITES
The professor who `cured` his cancer with a cocktail of everyday pills and 20 years on remains disease-free
Cancer drug first tested in pet dogs begins human trials
Cancer Immunotherapy presentation
02/25/2015
UCLA 15th Annual Brain Tumor Conference
02/23/2015
Celldex`s Rindopepimut (Rintega(R)) Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma
02/21/2015
Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.
End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma
02/13/2015
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
02/10/2015
Could There Be a Gleevec for Brain Cancer?
"Historic Moment"
02/09/2015
Dr. Howard Fine Named Founding Director of the Brain Tumor Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center
02/04/2015
High hopes
02/02/2015
Dr. Howard Fine moved to Cornell!
01/31/2015
One Dose, Then Surgery: A New Way to Test Brain Tumor Drugs
Helmet-like device treats recurrent brain cancer